Zymeworks Inc. Share Price
NASDAQ: ZYME | Mid CapZymeworks Inc. Stock Performance
Zymeworks Inc. Share Price Today
As of 30 October 2026, Zymeworks Inc.'s share price is $28.41. The stock opened at $28.45, compared to its previous close of $28.73. During today's trading session, Zymeworks Inc.'s share price traded between $28.41 and $28.45, with an average price of $28.43. Over the past 52 weeks, the stock has recorded a high of $31.20 and a low of $16.31. In terms of performance, Zymeworks Inc.'s share price has risen by 3.03% over the last six months and is up 48.82% on a year-on-year basis.
Zymeworks Inc. Share Price Chart
Zymeworks Inc. Quarterly Profit & Loss
All figures in USD
Zymeworks Inc. Annual Profit & Loss
All figures in USD
About Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Zymeworks Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $26.43 | $28.41 | +7.17% |
Sep 2026 | $29.07 | $26.51 | -8.57% |
Aug 2026 | $22.02 | $29.00 | +32.04% |
Jul 2026 | $26.18 | $21.96 | -16.45% |
Jun 2026 | $24.84 | $26.29 | +4.66% |
May 2026 | $26.97 | $25.11 | -8.92% |
Apr 2026 | $25.04 | $27.57 | +10.17% |
Mar 2026 | $22.91 | $25.03 | +7.29% |
Feb 2026 | $22.70 | $23.33 | +3.46% |
Jan 2026 | $26.04 | $22.55 | -14.39% |
Dec 2025 | $26.29 | $26.34 | -1.50% |
Nov 2025 | $18.99 | $26.74 | +40.07% |